Erratum: MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor1 and angiotensin II (Human Molecular Genetics (2007) vol. 16 (20) (2453-2462) 10.1093/hmg/ddm201);MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II

Human Molecular Genetics

Volumn 16, Issue 20, 2007, Pages 2453-2462

  Pannu, Hariyadarshi ^a   Tran Fadulu, Van ^a   Papke, Christina L ^a   Scherer, Steve ^b   Liu, Yaozhong ^a   Presley, Caroline ^a   Guo, Dongchuan ^a   Estrera, Anthony L ^a   Safi, Hazim J ^a   Brasier, Allan R ^c   Vick, G Wesley ^b   Marian, A J ^a   Raman, C S ^a   Buja, L Maximilian ^a   Milewicz, Dianna M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 11; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AORTA DISSECTION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC ANALYSIS; GENETIC IDENTIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NON-SYNDROMIC THORACIC AORTIC ANEURYSMS AND DISSECTIONS; PATENT DUCTUS ARTERIOSUS; PHENOTYPE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; THORACIC AORTA ANEURYSM; THORAX SURGERY; UPREGULATION;

EID: 34848825045     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm313     Document Type: Erratum

References (38)

1. Lilienfeld, D.E., Gunderson, P.D., Sprafka, J.M. and Vargas, C. (1987) Epidemiology of aortic aneurysms: I. Mortality trends in the United States, 1951 to 1981. Arteriosclerosis, 7, 637-643.
2. Lindsay, J., Jr. (1997) Diagnosis and treatment of diseases of the aorta. Curr. Probl. Cardiol., 22, 485-542.
3. Biddinger, A., Rocklin, M., Coselli, J. and Milewicz, D.M. (1997) Familial thoracic aortic dilatations and dissections: A case control study. J. Vasc. Surg., 25, 506-511.
4. Coady, M.A., Davies, R.R., Roberts, M., Goldstein, L.J., Rogalski, M.J., Rizzo, J.A., Hammond, G.L., Kopf, G.S. and Elefteriades, J.A. (1999) Familial patterns of thoracic aortic aneurysms. Arch. Surg., 134, 361-367.
5. Loeys, B.L., Chen, J., Neptune, E.R., Judge, D.P., Podowski, M., Holm, T., Meyers, J., Leitch, C.C., Katsanis, N., Sharifi, N. et al. (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet., 37, 275-281.
6. Guo, D., Hasham, S., Kuang, S.Q., Vaughan, C.J., Boerwinkle, E., Chen, H., Abuelo, D., Dietz, H.C., Basson, C.T., Shete, S.S. and Milewicz, D.M. (2001) Familial thoracic aortic aneurysms and dissections: Genetic heterogeneity with a major locus mapping to 5q13-14. Circulation, 103, 2461-2468.
7. Vaughan, C.J., Casey, M., He, J., Veugelers, M., Henderson, K., Guo, D., Campagna, R., Roman, M.J., Milewicz, D.M., Devereux, R.B. and Basson, C.T. (2001) Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation, 103, 2469-2475.
8. Hasham, S.N., Willing, M.C., Guo, D.C., Muilenburg, A., He, R., Tran, V.T., Scherer, S.E., Shete, S.S. and Milewicz, D.M. (2003) Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25. Circulation, 107, 3184-3190.
9. Van Kien, P.K., Mathieu, F., Zhu, L., Lalande, A., Betard, C., Lathrop, M., Brunotte, F., Wolf, J.E. and Jeunemaitre, X. (2005) Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12.2-p13.13. Circulation, 112, 200-206.
10. Pannu, H., Fadulu, V., Chang, J., Lafont, A., Hasham, S.N., Sparks, E., Giampietro, P.F., Zaleski, C., Estrera, A.L., Safi, H.J. et al. (2005) Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 112, 513-520.
11. Zhu, L., Vranckx, R., Van Kien, P.K., Lalande, A., Boisset, N., Mathieu, F., Wegman, M., Glancy, L., Gasc, J.M., Brunotte, F. et al. (2006) Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat. Genet., 38, 343-349.
12. Dillon, P.F., Aksoy, M.O., Driska, S.P. and Murphy, R.A. (1981) Myosin phosphorylation and the cross-bridge cycle in arterial smooth muscle. Science, 211, 495-497.
13. Vale, R.D. and Milligan, R.A. (2000) The way things move: Looking under the hood of molecular motor proteins. Science, 288, 88-95.
14. Rayment, I., Rypniewski, W.R., Schmidt-Base, K., Smith, R., Tomchick, D.R., Benning, M.M., Winkelmann, D.A., Wesenberg, G. and Holden, H.M. (1993) Three-dimensional structure of myosin subfragment-1: A molecular motor. Science, 261, 50-58.
15. Huston, E.E., Grammer, J.C. and Yount, R.G. (1988) Flexibility of the myosin heavy chain: Direct evidence that the region containing SH1 and SH2 can move 10 A under the influence of nucleotide binding. Biochemistry, 27, 8945-8952.
16. Lalwani, A.K., Goldstein, J.A., Kelley, M.J., Luxford, W., Castelein, C.M. and Mhatre, A.N. (2000) Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am. J. Hum. Genet., 67, 1121-1128.
17. Iwai, S., Hanamoto, D. and Chaen, S. (2006) A point mutation in the SH1 helix alters elasticity and thermal stability of myosin II. J. Biol. Chem., 281, 30736-30744.
18. Kohler, J., Winkler, G., Schulte, I., Scholz, T., McKenna, W., Brenner, B. and Kraft, T. (2002) Mutation of the myosin converter domain alters cross-bridge elasticity. Proc. Natl Acad. Sci. USA, 99, 3557-3562.
19. Habashi, J.P., Judge, D.P., Holm, T.M., Cohn, R.D., Loeys, B.L., Cooper, T.K., Myers, L., Klein, E.C., Liu, G., Calvi, C. et al. (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science, 312, 117-121.
20. Chambers, R.C., Leoni, P., Kaminski, N., Laurent, G.J. and Heller, R.A. (2003) Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am. J. Pathol., 162, 533-546.
21. Milewicz, D.M., Dietz, H.C. and Miller, D.C. (2005) Treatment of aortic disease in patients with Marfan syndrome. Circulation, 111, e150-e157.
22. Geisterfer-Lowrance, A.A., Kass, S., Tanigawa, G., Vosberg, H.P., McKenna, W., Seidman, C.E. and Seidman, J.G. (1990) A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell, 62, 999-1006.
23. Ho, C.Y. and Seidman, C.E. (2006) A contemporary approach to hypertrophic cardiomyopathy. Circulation, 113, e858-e862.
24. Ahmad, F., Seidman, J.G. and Seidman, C.E. (2005) The genetic basis for cardiac remodeling. Annu. Rev. Genomics Hum. Genet., 6, 185-216.
25. Hughes, S.E. (2004) The pathology of hypertrophic cardiomyopathy. Histopathology, 44, 412-427.
26. Broglio, F., Fubini, A., Morello, M., Arvat, E., Aimaretti, G., Gianotti, L., Boghen, M.F., Deghenghi, R., Mangiardi, L. and Ghigo, E. (1999) Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Clin. Endocrinol. (Oxf), 50, 417-430.
27. Li, G., Borger, M.A., Williams, W.G., Weisel, R.D., Mickle, D.A., Wigle, E.D. and Li, R.K. (2002) Regional overexpression of insulin-like growth factor-I and transforming growth factor-beta1 in the myocardium of patients with hypertrophic obstructive cardiomyopathy. J Thorac. Cardiovasc. Surg., 123, 89-95.
28. Marian, A.J. and Roberts, R. (2001) The molecular genetic basis for hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol., 33, 655-670.
29. Lim, D.S., Lutucuta, S., Bachireddy, P., Youker, K., Evans, A., Entman, M., Roberts, R. and Marian, A.J. (2001) Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation, 103, 789-791.
30. Standley, P.R., Obards, T.J. and Martina, C.L. (1999) Cyclic stretch regulates autocrine IGF-I in vascular smooth muscle cells: Implications in vascular hyperplasia. Am. J. Physiol., 276, E697-E705.
31. Allen, T.R., Krueger, K.D., Hunter, W.J., III and Agrawal, D.K. (2005) Evidence that insulin-like growth factor-1 requires protein kinase C-epsilon, PI3-kinase and mitogen-activated protein kinase pathways to protect human vascular smooth muscle cells from apoptosis. Immunol. Cell Biol., 83, 651-667.
32. Recinos, A.I.I.I., Lejeune, W.S., Sun, H., Lee, C.Y., Tieu, B.C., Lu, M., Hou, T., Boldogh, I., Tilton, R.G. and Brasier, A.R. (2006) Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice. Atherosclerosis, doi: 10.1016/j.atherosclerosis.2006.10.
33. Clyman, R.I. (2006) Mechanisms regulating the ductus arteriosus. Biol. Neonate, 89, 330-335.
34. He, R., Guo, D.C., Estrera, A.L., Safi, H.J., Huynh, T.T., Yin, Z., Cao, S.N., Lin, J., Kurian, T., Buja, L.M. et al. (2006) Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J. Thorac. Cardiovasc. Surg., 131, 671-678.
35. Jones, T.A., Zou, J.Y., Cowan, S.W. and Kjeldgaard, M. (1991) Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A, 47 (Pt 2), 110-119.
36. McDonald, I.K. and Thornton, J.M. (1994) Satisfying hydrogen bonding potential in proteins. J. Mol. Biol., 238, 777-793.
37. Delano, W.L. (2002) The PyMOL User's Manual. DeLano Scientific, San Carlos, CA, USA.
38. Lupas, A., Van Dyke, M. and Stock, J. (1991) Predicting coiled coils from protein sequences. Science, 252, 1162-1164.